Plasma as an alternative COVID-19 diagnostic specimen in a hospitalized patient negative for SARS-CoV-2 by nasopharyngeal swab
- 4 March 2021
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 100 (3), 115365
- https://doi.org/10.1016/j.diagmicrobio.2021.115365
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Plasma Is Associated With Intensive Care Unit Admission and Mortality in Patients Hospitalized With Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild IllnessPublished by Cold Spring Harbor Laboratory ,2020
- False Negative Tests for SARS-CoV-2 Infection - Challenges and ImplicationsThe New England Journal of Medicine, 2020
- Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2Journal of Clinical Virology, 2020
- The Brief Case: “Not Positive” or “Not Sure”—COVID-19-Negative Results in a Symptomatic PatientJournal of Clinical Microbiology, 2020
- The Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019 (COVID-19): Antigen TestingClinical Infectious Diseases, 2020
- Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19Journal of Clinical Microbiology, 2020